|1.||Oxvig, Claus: 4 articles (10/2015 - 01/2013)|
|2.||Conover, Cheryl A: 4 articles (10/2015 - 12/2006)|
|3.||Frystyk, Jan: 3 articles (10/2015 - 03/2015)|
|4.||Hjortebjerg, Rikke: 3 articles (10/2015 - 03/2015)|
|5.||Brooks, Peter C: 3 articles (01/2015 - 01/2008)|
|6.||Resch, Zachary T: 3 articles (02/2014 - 12/2006)|
|7.||Durai, Rajaraman: 3 articles (04/2007 - 06/2006)|
|8.||Goldspink, Geoffrey: 3 articles (04/2007 - 06/2006)|
|9.||Baylink, D J: 3 articles (02/2001 - 02/2000)|
|10.||Mohan, S: 3 articles (02/2001 - 02/2000)|
09/01/2007 - "This study assessed the effects of overexpression of IGFBP-4 on the development of cancer in vivo. "
11/15/2011 - "The Wnt/β-catenin signaling pathway is inactivated by Wnt antagonists in most cancers and IGFBP-4 is an antagonist of the Wnt/ β-catenin signaling pathway. "
01/01/2011 - "We also reported that MMTV-Skp2B transgenic mice develop mammary gland tumors that are characterized by an increased proteolytic cleavage of the insulin-like growth factor binding protein 4 (IGFBP-4), an inhibitor of IGF signaling. "
06/01/2006 - "The effect of altered expression of IGFBP-4 in vivo in colon and other cancers needs to be explored as locally available IGFs appear to stimulate mitogenesis."
06/01/2006 - "However, the effects of IGFBP-4 on tumor growth are uncertain. "
|2.||Neoplasm Metastasis (Metastasis)
02/01/2014 - "The HCC-BDTT demonstrated increased expression in IL-6 and stemness factor Bmi1, but reduced level of metastasis-suppressive protein, insulin-like growth factor-binding protein 4. The invasive ability of the highly aggressive Mahlavu cell was attenuated by pre-miR-200c+141, whereas the invasive ability of the less aggressive Huh7 cell was enhanced by anti-miR-200c+141. "
11/15/2011 - "This is a first report documenting that IGFBP-4 expression in RCC activates cell growth, metastasis, Wnt/beta-catenin signaling and may be involved in RCC metastasis."
04/10/2004 - "Here, we show that regulation of uPA mRNA and protein by IGF-I depends on the PI3K and MAPK signaling pathways and phosphorylation of Akt and ERK1/2 is required for IGF-I-mediated cell invasion; that IGFBP-4 protease in HRA cells is identified as PAPP-A; that reduced PAPP-A expression is associated with the upregulation of IGFBP-4 expression; that higher intact IGFBP-4 levels were associated with low invasive potential and growth rate in AS-PAPP-A cells in response to IGF-I; that IGF-I stimulates Akt and ERK1/2 activation of both the control and antisense cells, but the relative potency and efficacy of IGF-I were lower in the antisense cells compared to the control; and that genetic downregulation of PAPP-A reduces the proliferation, invasion and metastasis of HRA cells. "
|3.||Colonic Neoplasms (Colon Cancer)
06/01/2006 - "In vitro studies have shown that overexpression of IGFBP-4 inhibit the growth of some colon cancer cells. "
07/01/2013 - "Our results demonstrate, for the first time, that SOX9 is a transcriptional regulator of IGFBP-4 and that SOX9-induced activation of IGFBP-4 may be one of the mechanisms by which SOX9 suppresses cell proliferation and progression of colon cancer."
01/01/2007 - "Nude mice were subcutaneously inoculated with HT-29 colon cancer cells and they were also simultaneously injected either gene construct containing mammalian expression vector pcDNA3 with or without IGFBP-4 gene or phosphate buffered saline. "
01/01/2007 - "We assessed the effect of IGFBP-4 in prevention of development of colon cancer in vivo. "
02/10/2005 - "Our data indicate that IGFBP-4 is involved in the regulation of gene products that are known or supposed to be important for the pathogenesis of colon cancer cells."
|4.||Osteosarcoma (Osteogenic Sarcoma)
04/01/1995 - "Simian virus-40-immortalized hOB cells (HOBIT), human osteosarcoma cells (TE-85), and rat osteosarcoma cells (UMR 106-01, ROS 17/2.8) secrete IGFBP-4. "
04/01/1995 - "HOBIT cells, but not the osteosarcoma cell lines, appeared to produce a cycloheximide-sensitive inhibitor of the IGFBP-4 proteolytic reaction. "
01/01/1994 - "In this study, we have identified IGFBP-4 and IGFBP-5 protease activity in the conditioned medium (CM) of the human osteosarcoma U2 cell line (U2OS) and untransformed normal human bone cell (HBC) derived from skull. "
02/01/2001 - "To evaluate the role of serum PAPP-A, we tested whether PAPP-A in PS modulated the inhibitory activity of IGFBP-4 on IGF-II-induced cell proliferation in human osteosarcoma MG63 cells. "
12/01/1992 - "In this study, we sought to determine by Western ligand blotting the effects of growth hormone, IGF-I and IGF-II on the production of IGFBP-3 and IGFBP-4 in TE89 human osteosarcoma cells and in untransformed normal human bone cells derived from rib. "
11/01/1992 - "The effect of IGFs on IGFBP-4 levels in fibroblast conditioned media is not mediated via the type 1 or type 2 cellular IGF receptors, and the IGFs exert little or no effects on IGFBP-4 messenger RNA levels in human adult fibroblasts or in rat neuroblastoma cells. "
04/01/1996 - "In this study, SK-N-SH neuroblastoma cells were shown to produce IGF-II, IGFBP-2, IGFBP-4 and small quantities of IGFBP-6. "
11/01/1998 - "Retinoic acid stimulates IGF binding protein (IGFBP)-6 and depresses IGFBP-2 and IGFBP-4 in SK-N-SH human neuroblastoma cells."
06/01/1991 - "Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4."
|1.||Insulin-Like Growth Factor I (IGF-1)
|2.||Insulin-Like Growth Factor Binding Protein 3
|3.||Messenger RNA (mRNA)
|4.||Pregnancy-Associated Plasma Protein-A (PAPP-A)
|5.||Insulin-Like Growth Factor Binding Protein 2
|6.||Insulin-Like Growth Factor II (Somatomedin A)
|7.||Insulin-Like Growth Factor Binding Protein 5
|8.||Insulin-Like Growth Factor Binding Protein 6
|10.||Insulin-Like Growth Factor Binding Protein 1
|2.||Heterologous Transplantation (Xenotransplantation)